# FDA Seeks Guidance from the Digital Health Advisory Committee on AI: Considerations for Innovators of Digital Mental Health Medical Devices and Wellness Products - JD Supra

## Metadata
| Field | Value |
|-------|-------|
| Source | JD Supra |
| URL | https://news.google.com/rss/articles/CBMihAFBVV95cUxPZzJZUkpoeE1WOC1BQy1VTTdFbjROMGNwTVBrUlZGWE9MM0dqWTBQM0gwR3RzaloyX25YNnRpbVZGV2ZYdEN2Y2dwMFNYaDF6Q1JRd25tSXN0RDlMM0RncE5jODFtMTNrQUZDZUhFMmJJQzg1R0NmZUJLMThiMWE2bjZkRHc?oc=5&hl=en-US&gl=US&ceid=US:en |
| Scraped | 2025-12-30 18:01 |
| Category | Regulatory|Mental Health|AI |
| Relevance | 8/10 |
| Signal | bull |

## Investment Summary
FDA is proactively seeking guidance on AI-powered digital mental health medical devices and wellness products, signaling increased regulatory attention and potential market opportunities in digital mental health technologies.

## Key Entities
FDA, Digital Health Advisory Committee

## Dollar Amounts
None mentioned

---

## Article Content

*Full content could not be extracted. Visit URL for details.*

---

#healthcare-news #regulatory|mental-health|ai #auto-scraped
